Looking for the high way in EGFR-positive non-small cell lung cancer through the evaluation of survival endpoints

Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S334-S338. doi: 10.21037/tlcr.2019.06.04.

Authors

Antonio Passaro¹, Filippo de Marinis¹

Affiliation

¹ Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

No abstract available

Publication types

Editorial
Comment